Metabolomic profiling of a neurodegenerative retina following optic nerve transection

The degeneration of retinal ganglion cells (RGCs) often causes irreversible vision impairment. Prevention of RGC degeneration can prevent or delay the deterioration of visual function. The present study aimed to investigate retinal metabolic profiles following optic nerve transection (ONT) injury and identify the potential metabolic targets for the prevention of RGC degeneration. Retinal samples were dissected from ONT group and non-ONT group. The untargeted metabolomics were carried out using liquid chromatography-tandem mass spectrometry. The involved pathways and biomarkers were analyzed using Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis and MetaboAnalyst 5.0. In the ONT group, 689 disparate metabolites were detected, including lipids and lipid-like molecules. A total of 122 metabolites were successfully annotated and enriched in 50 KEGG pathways. Among them, ‘sphingolipid metabolism’ and ‘primary bile acid biosynthesis’ were identified involved in RGC degeneration. A total of five metabolites were selected as the candidate biomarkers for detecting RGC degeneration with an AUC value of 1. The present study revealed that lipid-related metabolism was involved in the pathogenesis of retinal neurodegeneration. Taurine, taurochenodesoxycholic acid, taurocholic acid (TCA), sphingosine, and galabiosylceramide are shown as the promising biomarkers for the diagnosis of RGC degeneration.

[1]  Xiaona Ma,et al.  Induced neural stem cells suppressed neuroinflammation by inhibiting the microglial pyroptotic pathway in intracerebral hemorrhage rats , 2023, iScience.

[2]  Ying Zhang,et al.  Proteomic analysis of vitreal exosomes in patients with proliferative diabetic retinopathy , 2022, Eye.

[3]  Kaibo Yang,et al.  Metagenomic shotgun sequencing and metabolomic profiling identify specific human gut microbiota associated with diabetic retinopathy in patients with type 2 diabetes , 2022, Frontiers in Immunology.

[4]  M. Naash,et al.  Riboflavin deficiency leads to irreversible cellular changes in the RPE and disrupts retinal function through alterations in cellular metabolic homeostasis , 2022, Redox biology.

[5]  F. Tomás-Barberán,et al.  Production of New Microbially Conjugated Bile Acids by Human Gut Microbiota , 2022, Biomolecules.

[6]  B. Evans,et al.  Analysis of the Ability of Capsaicin to Modulate the Human Gut Microbiota In Vitro , 2022, Nutrients.

[7]  C. Barbas,et al.  Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  Xinghuai Sun,et al.  Association Between Sex Hormones and Visual Field Progression in Women With Primary Open Angle Glaucoma: A Cross-Sectional and Prospective Cohort Study , 2021, Frontiers in Aging Neuroscience.

[9]  Nan-Kai Wang,et al.  Role of Oxidative Stress in Ocular Diseases Associated with Retinal Ganglion Cells Degeneration , 2021, Antioxidants.

[10]  Guozhen Duan,et al.  Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5 , 2021, Molecules.

[11]  N. Çağıl,et al.  Evaluation of sphingolipid metabolism on diabetic retinopathy , 2021, Indian journal of ophthalmology.

[12]  R. Shiekhattar,et al.  Identification of long noncoding RNAs in injury-resilient and injury-susceptible mouse retinal ganglion cells , 2021, BMC Genomics.

[13]  J. B. Demb,et al.  Preservation of vision after CaMKII-mediated protection of retinal ganglion cells , 2021, Cell.

[14]  A. Di Polo,et al.  AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma , 2021, Molecular Neurodegeneration.

[15]  N. Nakaya,et al.  miRNA Changes in Retinal Ganglion Cells after Optic Nerve Crush and Glaucomatous Damage , 2021, Cells.

[16]  C. Gerloff,et al.  Sphingosine‐1‐Phosphate, Motor Severity, and Progression in Parkinson's Disease (MARK‐PD) , 2021, Movement disorders : official journal of the Movement Disorder Society.

[17]  Ja-Kyeong Lee,et al.  Taurine Protects against Postischemic Brain Injury via the Antioxidant Activity of Taurine Chloramine , 2021, Antioxidants.

[18]  A. Kijlstra,et al.  Identification of Urine Metabolic Biomarkers for Vogt-Koyanagi-Harada Disease , 2021, Frontiers in Cell and Developmental Biology.

[19]  A. Di Minno,et al.  The evolving landscape of untargeted metabolomics. , 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[20]  C. Orssaud,et al.  A plasma metabolomic signature of Leber hereditary optic neuropathy showing taurine and nicotinamide deficiencies , 2021, Human molecular genetics.

[21]  E. Cho,et al.  Methylene blue promotes survival and GAP-43 expression of retinal ganglion cells after optic nerve transection. , 2020, Life sciences.

[22]  Jiun L. Do,et al.  Sheath-Preserving Optic Nerve Transection in Rats to Assess Axon Regeneration and Interventions Targeting the Retinal Ganglion Cell Axon. , 2020, Journal of Visualized Experiments.

[23]  F. Quintana,et al.  Role of sphingolipid metabolism in neurodegeneration , 2020, Journal of neurochemistry.

[24]  Robert V Farese,et al.  Inhibition of sphingolipid synthesis improves outcomes and survival in GARP mutant wobbler mice, a model of motor neuron degeneration , 2020, Proceedings of the National Academy of Sciences.

[25]  M. Brantley,et al.  Taurocholic acid inhibits features of age-related macular degeneration in vitro. , 2020, Experimental eye research.

[26]  D. Chen,et al.  Adaptive Immunity: New Aspects of Pathogenesis Underlying Neurodegeneration in Glaucoma and Optic Neuropathy , 2020, Frontiers in Immunology.

[27]  R. Diem,et al.  Influence of retinal NMDA receptor activity during autoimmune optic neuritis , 2020, Journal of neurochemistry.

[28]  D. Milea,et al.  A Data Mining Metabolomics Exploration of Glaucoma , 2020, Metabolites.

[29]  J. Chiang,et al.  Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. , 2020, American journal of physiology. Gastrointestinal and liver physiology.

[30]  Charles M. Lieber,et al.  Single-Cell Profiles of Retinal Ganglion Cells Differing in Resilience to Injury Reveal Neuroprotective Genes , 2019, Neuron.

[31]  S. Siniossoglou,et al.  Rewiring Neuronal Glycerolipid Metabolism Determines the Extent of Axon Regeneration , 2019, Neuron.

[32]  D. Zacks,et al.  A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma , 2019, Journal of Neuroinflammation.

[33]  Vishnu Shankar,et al.  Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration , 2019, bioRxiv.

[34]  O. Isacson,et al.  Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease , 2019, Journal of Neuroinflammation.

[35]  Markus M. Rinschen,et al.  Identification of bioactive metabolites using activity metabolomics , 2019, Nature Reviews Molecular Cell Biology.

[36]  J. Koistinaho,et al.  Dysfunction of Cellular Proteostasis in Parkinson’s Disease , 2019, Front. Neurosci..

[37]  R. Agarwal,et al.  Taurine protects against NMDA-induced retinal damage by reducing retinal oxidative stress , 2019, Amino Acids.

[38]  Y. Shao,et al.  Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease , 2019, Molecular Neurodegeneration.

[39]  S. Tsoi,et al.  Gene ontology analysis of expanded porcine blastocysts from gilts fed organic or inorganic selenium combined with pyridoxine , 2018, BMC Genomics.

[40]  Chengping Wen,et al.  Urinary Metabolomics Study of Patients with Gout Using Gas Chromatography-Mass Spectrometry , 2018, BioMed research international.

[41]  D. Milea,et al.  A Metabolomics Profiling of Glaucoma Points to Mitochondrial Dysfunction, Senescence, and Polyamines Deficiency. , 2018, Investigative Ophthalmology and Visual Science.

[42]  J. Crowston,et al.  The coma in glaucoma: Retinal ganglion cell dysfunction and recovery , 2018, Progress in Retinal and Eye Research.

[43]  Machelle T. Pardue,et al.  Neuroprotective strategies for retinal disease , 2018, Progress in Retinal and Eye Research.

[44]  A. D’Alessandro,et al.  Metabolomics Analysis of Human Vitreous in Diabetic Retinopathy and Rhegmatogenous Retinal Detachment. , 2018, Journal of proteome research.

[45]  Xiu-Miao Li,et al.  Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge , 2018, Theranostics.

[46]  P. Brundin,et al.  Biochemical Profiling of the Brain and Blood Metabolome in a Mouse Model of Prodromal Parkinson's Disease Reveals Distinct Metabolic Profiles. , 2018, Journal of proteome research.

[47]  Ilya Gertsman,et al.  Promises and pitfalls of untargeted metabolomics , 2018, Journal of Inherited Metabolic Disease.

[48]  J. Silver,et al.  The Biology of Regeneration Failure and Success After Spinal Cord Injury. , 2018, Physiological reviews.

[49]  Xianlin Han,et al.  Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome , 2018, Alzheimer's & Dementia.

[50]  M. Heneka,et al.  Activation of the NLRP3 inflammasome in microglia: the role of ceramide , 2017, Journal of neurochemistry.

[51]  Yong-long Han,et al.  Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia , 2017, Journal of cachexia, sarcopenia and muscle.

[52]  Y. Hannun,et al.  Alkaline Ceramidase 1 Protects Mice from Premature Hair Loss by Maintaining the Homeostasis of Hair Follicle Stem Cells , 2017, Stem cell reports.

[53]  G. Coppola,et al.  Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function , 2017, Current neuropharmacology.

[54]  R. Libby,et al.  JUN is important for ocular hypertension-induced retinal ganglion cell degeneration , 2017, Cell Death & Disease.

[55]  C. Falany,et al.  Carboxy-terminal mutations of bile acid CoA:N-acyltransferase alter activity and substrate specificity , 2016, Journal of Lipid Research.

[56]  Wei Jia,et al.  Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis. , 2016, Journal of proteome research.

[57]  J. Milbrandt,et al.  Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism , 2016, Neuron.

[58]  Caroline H. Johnson,et al.  Global metabolomics reveals metabolic dysregulation in ischemic retinopathy , 2015, Metabolomics.

[59]  K. Uppal,et al.  Metabolome-Wide Association Study of Primary Open Angle Glaucoma. , 2015, Investigative ophthalmology & visual science.

[60]  J. Stiban,et al.  Regulation of ceramide channel formation and disassembly: Insights on the initiation of apoptosis , 2015, Saudi journal of biological sciences.

[61]  M. Pinazo-Durán,et al.  Metabolomics of the aqueous humor in the rat glaucoma model induced by a series of intracamerular sodium hyaluronate injection. , 2015, Experimental eye research.

[62]  P. D'Onofrio,et al.  Neuronal Injury External to the Retina Rapidly Activates Retinal Glia, Followed by Elevation of Markers for Cell Cycle Re-Entry and Death in Retinal Ganglion Cells , 2014, PloS one.

[63]  Sander R. Dubovy,et al.  Human trabecular meshwork sphingolipid and ceramide profiles and potential latent fungal commensalism. , 2014, Investigative ophthalmology & visual science.

[64]  Derick R. Peterson,et al.  Plasma phospholipids identify antecedent memory impairment in older adults , 2014, Nature Medicine.

[65]  J. Mullor,et al.  Metabolomic changes in the rat retina after optic nerve crush. , 2013, Investigative ophthalmology & visual science.

[66]  Jang-Yen Wu,et al.  Neuroprotective Mechanisms of Taurine against Ischemic Stroke , 2013, Brain sciences.

[67]  B. Morquette,et al.  The molecular basis of retinal ganglion cell death in glaucoma , 2012, Progress in Retinal and Eye Research.

[68]  Frank Bradke,et al.  Assembly of a new growth cone after axotomy: the precursor to axon regeneration , 2012, Nature Reviews Neuroscience.

[69]  Jang-Yen Wu,et al.  Role of taurine in the central nervous system , 2010, Journal of Biomedical Science.

[70]  B. Garner.  Lipids and Alzheimer's disease. , 2010, Biochimica et biophysica acta.

[71]  M. Hunt,et al.  A peroxisomal acyltransferase in mouse identifies a novel pathway for taurine conjugation of fatty acids , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[72]  J. Woodcock.  Sphingosine and ceramide signalling in apoptosis , 2006, IUBMB life.

[73]  T. Rao,et al.  Microglial activation state and lysophospholipid acid receptor expression , 2003, International Journal of Developmental Neuroscience.

[74]  L. Levin,et al.  Retinal ganglion cell disorders: types and treatments , 2002, Progress in Retinal and Eye Research.

[75]  J. H. Lucas,et al.  Effects of Sodium and Chloride on Neuronal Survival After Neurite Transection , 2001, Journal of neuropathology and experimental neurology.

[76]  R. Singh,et al.  Sex hormones and diabetic retinopathy. , 1993, Annals of ophthalmology.

[77]  Scott B. Crown,et al.  Cardiovascular Metabolomics , 2018, Circulation research.

[78]  L. Obeid,et al.  Sphingolipids in mitochondria. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[79]  M. Maletic-Savatic,et al.  Metabolomics of neurodegenerative diseases. , 2015, International review of neurobiology.

[80]  D. Stone,et al.  Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders. , 2014, Survey of ophthalmology.

[81]  P. Sastry,et al.  Lipids of nervous tissue: composition and metabolism. , 1985, Progress in lipid research.

[82]  S. Parlee,et al.  This Work Is Licensed under a Creative Commons Attribution-noncommercial 4.0 International License , 2022 .